These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27014089)

  • 41. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).
    Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M
    Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes.
    Rouvinski A; Gahali-Sass I; Stav I; Metzer E; Atlan H; Taraboulos A
    Biochem Biophys Res Commun; 2003 Sep; 308(4):750-8. PubMed ID: 12927782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice.
    Che H; Li Q; Zhang T; Wang D; Yang L; Xu J; Yanagita T; Xue C; Chang Y; Wang Y
    J Agric Food Chem; 2018 May; 66(19):4948-4957. PubMed ID: 29695154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
    Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
    Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
    Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
    Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma membrane injury depends on bilayer lipid composition in Alzheimer's disease.
    Evangelisti E; Zampagni M; Cascella R; Becatti M; Fiorillo C; Caselli A; Bagnoli S; Nacmias B; Cecchi C
    J Alzheimers Dis; 2014; 41(1):289-300. PubMed ID: 24614900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid Raft Alterations in Aged-Associated Neuropathologies.
    Marin R; Fabelo N; Fernández-Echevarría C; Canerina-Amaro A; Rodríguez-Barreto D; Quinto-Alemany D; Mesa-Herrera F; Díaz M
    Curr Alzheimer Res; 2016; 13(9):973-84. PubMed ID: 26971937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition.
    Basiouni S; Stöckel K; Fuhrmann H; Schumann J
    Cell Immunol; 2012; 275(1-2):42-6. PubMed ID: 22486927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells.
    Cecchi C; Nichino D; Zampagni M; Bernacchioni C; Evangelisti E; Pensalfini A; Liguri G; Gliozzi A; Stefani M; Relini A
    Biochim Biophys Acta; 2009 Oct; 1788(10):2204-16. PubMed ID: 19651105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid composition of membrane microdomains isolated detergent-free from PUFA supplemented RAW264.7 macrophages.
    Hellwing C; Tigistu-Sahle F; Fuhrmann H; Käkelä R; Schumann J
    J Cell Physiol; 2018 Mar; 233(3):2602-2612. PubMed ID: 28782808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid raft disarrangement as a result of neuropathological progresses: a novel strategy for early diagnosis?
    Marin R; Rojo JA; Fabelo N; Fernandez CE; Diaz M
    Neuroscience; 2013 Aug; 245():26-39. PubMed ID: 23618758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing.
    Grimm MO; Haupenthal VJ; Mett J; Stahlmann CP; Blümel T; Mylonas NT; Endres K; Grimm HS; Hartmann T
    Neurodegener Dis; 2016; 16(1-2):44-54. PubMed ID: 26642316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligomerization of amyloid beta-protein occurs during the isolation of lipid rafts.
    Yu W; Zou K; Gong JS; Ko M; Yanagisawa K; Michikawa M
    J Neurosci Res; 2005 Apr; 80(1):114-9. PubMed ID: 15704187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM, and detergent extraction study.
    Shaikh SR; Dumaual AC; Castillo A; LoCascio D; Siddiqui RA; Stillwell W; Wassall SR
    Biophys J; 2004 Sep; 87(3):1752-66. PubMed ID: 15345554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
    Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimer's disease.
    Zhou X; Yang C; Liu Y; Li P; Yang H; Dai J; Qu R; Yuan L
    Neural Regen Res; 2014 Jan; 9(1):92-100. PubMed ID: 25206748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid rafts reconstituted in model membranes.
    Dietrich C; Bagatolli LA; Volovyk ZN; Thompson NL; Levi M; Jacobson K; Gratton E
    Biophys J; 2001 Mar; 80(3):1417-28. PubMed ID: 11222302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.